Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: Implications for viral latency and neurotropic transformation

Journal of Infectious Diseases

Volumn 199, Issue 6, 2009, Pages 881-888

  Tan, Chen S ^a,b   Dezube, Bruce J ^c   Bhargava, Parul ^e   Autissier, Patrick ^a   Wüthrich, Christian ^a   Miller, Janice ^a   Koralnik, Igor J ^a,d,e  

^a Division of Viral Pathogenesis   (United States)

^b Division of Infectious Diseases   (United States)

^c Division of Hematology and Oncology   (United States)

^d Boston University Medical Campus   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP1; VIRUS DNA; VIRUS LARGE T ANTIGEN;

ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CELL SELECTION; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JC VIRUS; MAJOR CLINICAL STUDY; NEUROTROPISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN EXPRESSION; URINALYSIS; VIRUS DETECTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANTIGENS, CD; BLOOD; BONE MARROW; DNA, VIRAL; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOHISTOCHEMISTRY; JC VIRUS; URINE; VIRAL PROTEINS; VIRUS LATENCY;

EID: 65649083713     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597117     Document Type: Article

References (50)

1. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1:1257-60.
2. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 2006; 60:162-73.
3. Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res 1983; 105:107-17.
4. Berger JR, Miller CS, Mootoor Y, Avdiushko SA, Kryscio RJ, Zhu H. JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis 2006; 43:e9-12.
5. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997; 176:250-4.
6. Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol 2001; 7:280-7.
7. Monaco MC, Shin J, Major EO. JC virus infection in cells from lymphoid tissue. Dev Biol Stand 1998; 94:115-22.
8. Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL. JC virusDNAload in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52:253-60.
9. Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 1996; 70: 7004-12.
10. Atwood WJ, Amemiya K, Traub R, Harms J, Major EO. Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992; 190:716-23.
11. Koralnik IJ, Schmitz JE, Lifton MA, Forman MA, Letvin NL. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1- infected individuals. J Neurovirol 1999; 5:430-5.
12. Houff SA, Major EO, Katz DA, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.NEngl J Med 1988; 318: 301-5.
13. Monaco MC, Jensen PN, Hou J, Durham LC, Major EO. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72:9918-23.
14. Katz DA, Berger JR, Hamilton B, Major EO, Post MJ. Progressive multifocal leukoencephalopathy complicating Wiskott-Aldrich syndrome: report of a case and review of the literature of progressive multifocal leukoencephalopathy with other inherited immunodeficiency states. Arch Neurol 1994; 51:422-6.
15. Schneider EM, Dorries K. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. Transplant Proc 1993; 25:1271-3.
16. Coppo P, Laporte JP, Aoudjhane M, et al. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999; 23:401-3.
17. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353:375-81.
18. Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353:369-74.
19. Van Assche G, Van Ranst M, Sciot R, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005; 353:362-8.
20. Biogen Idec. Form 8-K filing. United States Securities and Exchange Commission Web site. 31 July 2008. Available at: http://www.sec.gov/Archives/ edgar/data/875045/000095013508005223/b714958ke8vk.htm. Accessed 22 January 2009.
21. Ransohoff RM. "Thinking without thinking" about natalizumab and PML. J Neurol Sci 2007; 259:50-2.
22. Ransohoff RM. Natalizumab and PML. Nat Neurosci 2005; 8:1275.
23. Marzocchetti A, Wuthrich C, Tan CS, et al. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol 2008; 14:455-8.
24. Lima MA, Marzocchetti A, Autissier P, et al. Frequency and phenotype of JC virus-specific CD8- T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol 2007; 81:3361-8.
25. Wuthrich C, Kesari S, Kim WK, et al. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: colocalization of CD8- T cells with JCV-infected glial cells. J Neurovirol 2006; 12:116-28.
26. Klein E, Kis LL, Klein G. Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene 2007; 26:1297-305.
27. Khaiboullina SF, Maciejewski JP, Crapnell K, et al. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 2004; 126:410-7.
28. Koralnik IJ, Schellingerhout D, Frosch MP. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004: a 66-year-old man with progressive neurologic deficits.NEngl J Med 2004; 350:1882-93.
29. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4: 59-68.
30. Kaniowska D, Kaminski R, Amini S, et al. Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J Virol 2006; 80:9288-99.
31. Kim SY, Choi EC, Woo Jo Y, Henson JW, Kim HS. Transcriptional activation of JC virus early promoter by phorbol ester and interleukin- 1beta: critical role of nuclear factor-1. Virology 2004; 327:60-9.
32. Mischitelli M, Fioriti D, Videtta M, et al. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 2005; 204:913-8.
33. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 1990; 87:3479-83.
34. Berger JR, Chauhan A, Galey D, Nath A. Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J Neurovirol 2001; 7:329-38.
35. Sun NC, Shapshak P, Lachant NA, et al. Bone marrow examination in patients with AIDS and AIDS-related complex (ARC): morphologic and in situ hybridization studies. Am J Clin Pathol 1989; 92:589-94.
36. Weiser B, Burger H, Campbell P, Donelan S, Mladenovic J. HIV type 1 RNA expression in bone marrows of patients with a spectrum of disease. AIDS Res Hum Retroviruses 1996; 12:1551-8.
37. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70:1316-24.
38. Trowbridge PW, Frisque RJ. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. J Neurovirol 1995; 1:195-206.
39. Prins C, Frisque RJ. JC virus T' proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells. J Neurovirol 2001; 7:250-64.
40. White MK, Khalili K. Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer 2005; 41:2537-48.
41. Rabkin CS. Epidemiology of AIDS-related malignancies. Curr Opin Oncol 1994; 6:492-6.
42. Levine AM. Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol 2000; 27:442-53.
43. Biggar RJ, Curtis RE, Cote TR, Rabkin CS, Melbye M. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994; 139:362-8.
44. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98:2339-44.
45. Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol 2007; 60:1365-72.
46. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001; 285: 1736 - 45.
47. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005; 130:662-70.
48. Del Valle L, Enam S, Lara C, Miklossy J, Khalili K, Gordon J. Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol 2004; 78:3462-9.
49. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol 1984; 51:458-69.
50. Pfister LA, Letvin NL, Koralnik IJ. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 2001; 75:5672-6.